Paper39596757
Comprehensive Approaches to Combatting Acinetobacter baumannii Biofilms: From Biofilm Structure to Phage-Based Therapies.
Grygiel I and 7 others. Antibiotics (Basel), 2024. Cited by 32 papers, by iCite.
Cite this record
ConductScience Library. Comprehensive Approaches to Combatting Acinetobacter baumannii Biofilms: From Biofilm Structure to Phage-Based Therapies. Papers, record 39596757. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39596757
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Comprehensive Approaches to Combatting Acinetobacter baumannii Biofilms: From Biofilm Structure to Phage-Based Therapies.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References240
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27094331 | The Acinetobacter baumannii Two-Component System AdeRS Regulates Genes Required for Multidrug Efflux, Biofilm Formation, and Virulence in a Strain-Specific Manner. | mBio | 2016 | https://conductscience.org/library/papers/27094331 | PubMed |
| 2 | 11815572 | Effects of quorum-sensing deficiency on Pseudomonas aeruginosa biofilm formation and antibiotic resistance. | J Antimicrob Chemother | 2002 | https://conductscience.org/library/papers/11815572 | PubMed |
| 3 | 36677463 | Carbapenem-Resistant Acinetobacter baumannii: Biofilm-Associated Genes, Biofilm-Eradication Potential of Disinfectants, and Biofilm-Inhibitory Effects of Selenium Nanoparticles. | Microorganisms | 2023 | https://conductscience.org/library/papers/36677463 | PubMed |
| 4 | 21822035 | Antibiotic resistance mechanisms of clinically important bacteria. | Medicina (Kaunas) | 2011 | https://conductscience.org/library/papers/21822035 | PubMed |
| 5 | 9293187 | DNA gyrase, topoisomerase IV, and the 4-quinolones. | Microbiol Mol Biol Rev | 1997 | https://conductscience.org/library/papers/9293187 | PubMed |
| 6 | 27274985 | Mechanisms of Antimicrobial Resistance in ESKAPE Pathogens. | Biomed Res Int | 2016 | https://conductscience.org/library/papers/27274985 | PubMed |
| 7 | 36476854 | Bacterial MazF/MazE toxin-antitoxin suppresses lytic propagation of arbitrium-containing phages. | Cell Rep | 2022 | https://conductscience.org/library/papers/36476854 | PubMed |
| 8 | 11709311 | Resistance-nodulation-cell division-type efflux pump involved in aminoglycoside resistance in Acinetobacter baumannii strain BM4454. | Antimicrob Agents Chemother | 2001 | https://conductscience.org/library/papers/11709311 | PubMed |
| 9 | 35425613 | Phage-mediated horizontal gene transfer and its implications for the human gut microbiome. | Gastroenterol Rep (Oxf) | 2022 | https://conductscience.org/library/papers/35425613 | PubMed |
| 10 | 27538011 | Potential of a lytic bacteriophage to disrupt Acinetobacter baumannii biofilms in vitro. | Future Microbiol | 2016 | https://conductscience.org/library/papers/27538011 | PubMed |
| 11 | 15831827 | Metallo-beta-lactamases: the quiet before the storm? | Clin Microbiol Rev | 2005 | https://conductscience.org/library/papers/15831827 | PubMed |
| 12 | 9309367 | Permeation of antimicrobial agents through Pseudomonas aeruginosa biofilms: a simple method. | Chemotherapy | 1997 | https://conductscience.org/library/papers/9309367 | PubMed |
| 13 | 34736365 | Colistin-phage combinations decrease antibiotic resistance in Acinetobacter baumannii via changes in envelope architecture. | Emerg Microbes Infect | 2021 | https://conductscience.org/library/papers/34736365 | PubMed |
| 14 | 32547965 | Insights Into Mechanisms of Biofilm Formation in Acinetobacter baumannii and Implications for Uropathogenesis. | Front Cell Infect Microbiol | 2020 | https://conductscience.org/library/papers/32547965 | PubMed |
| 15 | 26767986 | Bacteriophage-encoded depolymerases: their diversity and biotechnological applications. | Appl Microbiol Biotechnol | 2016 | https://conductscience.org/library/papers/26767986 | PubMed |
| 16 | 35354477 | Bacteriophages and antibiotic interactions in clinical practice: what we have learned so far. | J Biomed Sci | 2022 | https://conductscience.org/library/papers/35354477 | PubMed |
| 17 | 29061747 | Effect of Incubation Temperature on Antibiotic Resistance and Virulence Factors of Acinetobacter baumannii ATCC 17978. | Antimicrob Agents Chemother | 2018 | https://conductscience.org/library/papers/29061747 | PubMed |
| 18 | 31169490 | Isolation and characterization of Siphoviridae phage infecting extensively drug-resistant Acinetobacter baumannii and evaluation of therapeutic efficacy in vitro and in vivo. | J Med Microbiol | 2019 | https://conductscience.org/library/papers/31169490 | PubMed |
| 19 | 34205838 | Mapping Global Prevalence of Acinetobacter baumannii and Recent Vaccine Development to Tackle It. | Vaccines (Basel) | 2021 | https://conductscience.org/library/papers/34205838 | PubMed |
| 20 | 38840247 | Characterizing the gut phageome and phage-borne antimicrobial resistance genes in pigs. | Microbiome | 2024 | https://conductscience.org/library/papers/38840247 | PubMed |
Cited by22
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 32 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42792077 | Synthesis and In Vitro Biological Evaluation of Amphiphilic Derivatives of Carvacrol as Potent Antibacterial Agents. | Antibiotics (Basel) | 2026 | https://conductscience.org/library/papers/42792077 | PubMed |
| 42529233 | Identification, resistance mechanisms, and innovative therapeutic approaches against Acinetobacter baumannii-calcoaceticus complex. | Front Microbiol | 2026 | https://conductscience.org/library/papers/42529233 | PubMed |
| 42527938 | An optimized CRISPR/Cas9-based genome editing platform enhances bacteriocin production in Lactiplantibacillus plantarum. | J Biol Eng | 2026 | https://conductscience.org/library/papers/42527938 | PubMed |
| 42428312 | Advances in phage therapy for Acinetobacter baumannii: mechanisms and applications. | Front Microbiol | 2026 | https://conductscience.org/library/papers/42428312 | PubMed |
| 42357673 | Protecting Newborns from Multidrug-Resistant Infections: The Emerging Role of Bacteriophages. | Viruses | 2026 | https://conductscience.org/library/papers/42357673 | PubMed |
| 42197354 | Synergistic Inhibition of Acinetobacter baumannii Biofilm Formation and Reduction of Lung Inflammation In Vivo by Combination of α-Pinene and Meropenem. | Microorganisms | 2026 | https://conductscience.org/library/papers/42197354 | PubMed |
| 42164670 | Phage enabled precision drug delivery: dual function platforms for therapeutics and genetic cargo transport. | Front Microbiol | 2026 | https://conductscience.org/library/papers/42164670 | PubMed |
| 42075299 | AUBFM01 Phage as a Therapeutic Candidate Against MDR Acinetobacter baumannii: Characterization, and Immune-Aware Profiling. | Microorganisms | 2026 | https://conductscience.org/library/papers/42075299 | PubMed |
| 42056714 | Acinetobacter baumannii: Mechanisms of antibiotic resistance, quorum sensing regulation, and current therapeutic strategies. | Virulence | 2026 | https://conductscience.org/library/papers/42056714 | PubMed |
| 41925945 | Isolation, characterization and genomic insights of the lytic bacteriophage TANUVAS_MVC-VPH-AB targeting Acinetobacter spp. with antibacterial and anti-biofilm activity. | Mol Biol Rep | 2026 | https://conductscience.org/library/papers/41925945 | PubMed |
| 41900873 | Bacteriophages as Therapeutic Agents for Pulmonary Infections: From Biological Principles to Clinical Applications. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/41900873 | PubMed |
| 41883474 | Mapping the global landscape of biofilm-associated antimicrobial resistance (1992-2025). | Biofilm | 2026 | https://conductscience.org/library/papers/41883474 | PubMed |
| 41762342 | A comprehensive analysis of the kinetics of infection of lytic bacteriophages specific to the ESKAPE and critical pathogens. | World J Microbiol Biotechnol | 2026 | https://conductscience.org/library/papers/41762342 | PubMed |
| 41711410 | Green and Ecofriendly Mycosynthesis of Nanocomposite Based on Zinc and Magnesium Oxide Nanoparticles Using Endophytic Sarocladium kiliense: Characterization, Anticancer Activity, Antimicrobial and Antibiofilm Activities. | Microbiologyopen | 2026 | https://conductscience.org/library/papers/41711410 | PubMed |
| 41705029 | Advancing climate-resilient livestock systems: Next-generation emission mitigation strategies and integrated technological innovations. | Vet Anim Sci | 2026 | https://conductscience.org/library/papers/41705029 | PubMed |
| 41472770 | Genomic and phenotypic insights into broad-spectrum anti-Escherichia coli activity of Lactiplantibacillus argentoratensis and Weissella cibaria isolated from swine feces: A sustainable alternative to antibiotics. | Vet World | 2025 | https://conductscience.org/library/papers/41472770 | PubMed |
| 41395476 | Penetrating the biofilm barrier: characterization of Escherichia phage vB_EcoS-TPF103dw and harnessing depolymerase to combat Shiga toxin-producing Escherichia coli O103 biofilm. | Front Microbiol | 2025 | https://conductscience.org/library/papers/41395476 | PubMed |
| 41178132 | Antibiofilm activity of a chionodracine-derived peptide by NMR-based metabolomics of cell-free supernatant of Acinetobacter baumannii clinical strains. | FEBS Open Bio | 2026 | https://conductscience.org/library/papers/41178132 | PubMed |
| 40635694 | Biofilms and multidrug resistance: an emerging crisis and the need for multidisciplinary interventions. | Front Bioeng Biotechnol | 2025 | https://conductscience.org/library/papers/40635694 | PubMed |
| 40608147 | Fighting biofilm: bacteriophages eliminate biofilm formed by multidrug-resistant Enterobacter hormaechei on urological catheters. | Med Microbiol Immunol | 2025 | https://conductscience.org/library/papers/40608147 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39596757
GET https://conductscience.org/api/papers/v1/39596757/references?page=2